Remibrutinib proves effective against chronic spontaneous urticaria, study

Study reveals Remibrutinib effective to treat Chronic Spontaneous Urticaria
Study reveals Remibrutinib effective to treat Chronic Spontaneous Urticaria

A new groundbreaking study revealed that Remibrutinib showed promising results in treating chronic spontaneous urticaria.

A recent study published in the New England Journal of Medicine outlined the potential of remibrutinib for patients suffering from symptomatic chronic spontaneous urticaria after being treated with second-generation H1-antihistamines, HealthDay reported.

Oral administration of remibrutinib, Bruton's tyrosine kinase inhibitor, was found beneficial, as it brings significant enhancement in a composite measure of hives at week 12.

Related: Regular lie-ins linked to higher risk of Alzheimer's, study

To assess the efficacy and safety of remibrutinib in patients, Charité–Universitätsmedizin Berlin MD Martin Metz and fellow researchers conducted a study.

They randomly assigned remibrutinib at a dose of 25 mg twice daily or placebo to 313 and 157 patients, in REMIX-1; 300 and 155 patients, respectively, in REMIX-2.

Eventually, researchers saw a significant improvement from baseline to week 12 in the urticaria activity during a seven-day period (UAS7).

Maximum patients in the remibrutinib group as compared to the placebo group scored 6 or lower on the UAS7 at week 12 (REMIX-1: 49.8 versus 24.8 percent; REMIX-2: 46.8 versus 19.6 percent), and a UAS7 score of 0 (REMIX-1: 31.1 versus 10.5 percent; REMIX-2: 27.9 versus 6.5 percent).

It is important to note that the adverse effects were similar in patients who were taking Remibrutinib and those who were taking a placebo.
Related: Hantavirus pulmonary syndrome: Everything you need to know

Related
Read more : Health

New Covid strain takes over UK with unique symptoms

New Covid strain takes over UK with unique symptoms
Stratus consists of two strains, XFG and XFG.2, which constitute up to 30% of cases across the UK

THESE common meds do not cause inflammatory bowel disease, study

THESE common meds do not cause inflammatory bowel disease, study
Medicines including NSAIDs like aspirin and ibuprofen, ACE inhibitors, aren’t linked to a higher risk of microscopic colitis

Juice, smoothies and soft drinks can dehydrate you in hot weather, say experts

Juice, smoothies and soft drinks can dehydrate you in hot weather, say experts
Alcohol should also be avoided in hot weather as it causes the body to lose water which often leads to dehydration

Excessive screen time linked to delayed learning in children, study

Excessive screen time linked to delayed learning in children, study
Experts warn too much screen time may hinder language development in young children

Chickpeas show surprising power to cut cholesterol levels in new study

Chickpeas show surprising power to cut cholesterol levels in new study
Those who ate chickpeas everyday showed a major improvement in their cholesterol levels

Air pollution fuels lung cancer in non-smokers, study

Air pollution fuels lung cancer in non-smokers, study
Air Pollution could drive lung cancer mutations in people with little to no history of smoking

15-minute workouts to rapidly lose weight

15-minute workouts to rapidly lose weight
Discover a few effective 15-minute workouts that are scientifically proven to rapidly help reduce fat

Measles outbreak spreads to Kentucky as US case tally reaches 1,267 this year

Measles outbreak spreads to Kentucky as US case tally reaches 1,267 this year
Health officials urge all parents to have their children vaccinated to ensure protection from measles